Abstract
Corticotropin-releasing hormone (CRH) signaling in the hippocampus has been established to be important for mediating the effects of stress on learning and memory. Given our laboratory’s recent characterization of a subset of hippocampal CRH neurons as a novel class of GABAergic interneurons, we hypothesized that these local GABAergic hippocampal CRH neurons may influence hippocampal function. Here we applied an array of molecular tools to selectively label and manipulate hippocampal CRH neurons in mice, in order to assess this interneuron population’s impact on hippocampus-dependent behaviors and hippocampal network excitability. Genetically-targeted ablation of hippocampal CRH neurons in vivo impaired object recognition memory and substantially enhanced the severity of kainic acid-induced seizures. Conversely, selective activation of CRH neurons in vitro suppressed the excitability of the mossy fiber-CA3 pathway. Additional experiments are needed to reconcile the functions of GABA and CRH signaling of hippocampal CRH neurons on hippocampal function. However, our results indicate that this interneuron population plays an important role in maintaining adaptive network excitability, and provide a specific circuit-level mechanism for this role.
Introduction
The hippocampus is critical for spatial navigation and episodic memory formation [1, 2]. Both of these tasks require precisely timed synchronous output, which is accomplished by over 20 distinct classes of hippocampal GABAergic interneurons [3, 4]. Furthermore, this must be done while clamping the overall excitability and synchrony of the hippocampus within an adaptive range, in order to avoid runaway excitation lead to an epileptic seizure, a pathological state of hypersynchronous hyperexcitability to which the hippocampus is particularly vulnerable [5, 6]. In order to better understand how interneurons accomplish this extremely delicate and dynamic balancing act, it is essential that we identify and thoroughly characterize hippocampal interneuron types. Each type is defined by a unique combination of characteristics, including its location within the hippocampus, molecular markers, firing patterns, and the subcellular localization of its synaptic contacts with pyramidal neurons [3]. Additionally, interneurons play a critical role in generating network-wide oscillations, and each interneuron type tends to fire only at specific phases of a given oscillation [7, 8]. For example, the extensively-studied basket cells are found in stratum pyramidale, express parvalbumin, and form contacts primarily on the cell bodies and proximal dendrites of pyramidal neurons; they can sustain rapid firing of action potentials, and tend to fire specifically on the descending phase of theta oscillations [9]. Taken together, the intrinsic properties and functional connectivity of an interneuron class provide valuable insight into their functions within the network such as the encoding of place fields, and pathogenic mechanisms for diseases such as epilepsy [10, 11]. Now, thanks to the development of cell type-specific genetic tools, we can selectively image and control the activity of individual interneuron types in mice. By assessing the impact of these manipulations on local network activity, hippocampus-dependent behavior, and pathological activity such as epileptic seizures, we can then begin to develop realistic models bridging the single unit, the local network, and higher-order brain functions and states.
We recently characterized the connectivity and intrinsic molecular and electrophysiological properties of a novel hippocampal interneuron type: the back-projecting corticotropin-releasing hormone (CRH) interneuron [12]. This unique class of hippocampal interneurons projects from CA1 stratum pyramidale to form extensive GABAergic synapses on CA3 principal cells, suggesting an important role in providing feedback inhibition to control the excitability of the trisynaptic circuit. However, to date functional studies of hippocampal CRH neurons have focused solely on the neuropeptide CRH itself, missing the potential impact of their synaptic connectivity [13, 14]. In the present study, we expand on our initial characterization by probing CRH interneurons’ relevance to hippocampus-dependent processes such as emotional behavior and recognition memory, as well as their impact on seizures in a model of temporal lobe epilepsy. Finally, we propose a circuit-level mechanism for these functional effects, based on back-projection CRH interneurons’ impact on the excitability of the mossy fiber-CA3 pathway.
Materials and methods
Animals
Adult (60–90 days old) mice were housed at the Tufts University School of Medicine, Division of Laboratory Animal Medicine, in clear plastic cages (four mice/cage) in a temperature- and humidity-controlled environment with a 12 h light/dark cycle (lights on at 0700 h) and ad libitum access to food and water. Only male mice were used in field potential recording experiments; in all other experiments, approximately equal numbers of male and female mice were used. All procedures were approved by the Tufts University Institutional Animal Care and Use Committee and adhered to the ethical guidelines presented in the National Institutes of Health Guide for the Care and Use of Laboratory Animals [15].
Transgenic mice expressing Cre recombinase under control of the CRH promotor (BAC CRH-Cre) were obtained from the Mutant Mouse Regional Resource Center (MMRRC) and have been described previously [16]. Knock-in mice expressing Cre recombinase under control of the endogenous CRH promotor (CRH-ires-Cre) were obtained from the Jackson Laboratory (Stock #012704). Mice expressing tdTomato specifically in CRH neurons (CRH-Ai9) were generated by crossing either BAC CRH-Cre or CRH-ires-Cre mice with floxed Ai9 mice (Jackson Lab, Stock #007909). Mice expressing tdTomato and Channelrhodopsin specifically in CRH neurons (ChR/CRH) were generated by crossing BAC CRH-Cre mice with floxed Channelrhodopsin mice (Jackson Laboratory, Stock #017455).
Virus injection and EEG surgery
Mice were anesthetized by intraperitoneal (i.p.) injection of a ketamine-xylazine mixture (100 mg/kg ketamine, 10 mg/kg xylazine). AAV2-GFP (Vector BioLabs #7004), AAV8-hSyn-DIO-hM3D(Gq)-mCherry (UNC Vectore Core), AAV8-hSyn-DIO-hM4D(Gi)-mCherry (UNC Vector Core), or AAV-FLEX-DTA (CMV-β-globin-DIO-mCherry-DTA-hGH pA generated by Dr. Patrick M. Fuller, Harvard Medical School) was stereotaxically injected into the dorsal hippocampus of each hemisphere (500 nL; posterior 2.0mm, lateral 1.5mm, depth 1.5mm) and the syringe was left in place for 5 minutes before withdrawal. For the EEG studies, mice were outfitted with an EEG/EMG headmount (Pinnacle #8201) utilizing stainless steel screws as two EEG leads, a reference electrode, EMG leads, and an animal ground. All animals were treated with buprenorphine (0.5mg/kg) preoperatively and then administered as needed to alleviate pain and/or distress to the animals during the three day postoperative observation period. Posthoc analysis was performed for each experiment to validate targeting and verify expected manipulations.
Immunohistochemistry
Mice were anesthetized by isoflurane inhalation, decapitated, and their brains were rapidly removed and fixed by immersion fixation in 4% paraformaldehyde overnight at 4°C. For CRH immunostaining, mice were instead transcardially perfused with phosphate-buffered saline and 4% paraformaldehyde before immersion fixation to improve staining quality. Brains were cryoprotected in 10% and 30% sucrose in phosphate-buffered saline, rapidly frozen in isopentane on dry ice, and stored at -80°C until 40 μm coronal sections were collected using a Leica cryostat. Sections were incubated with an antibody against CRH (1:10,000, rabbit, provided by Dr. Paul Sawchenko on behalf of Dr. Wylie Vale) or c-fos (1:10,000, rabbit, Calbiochem), followed by biotinylated anti-rabbit antibody (1:200, Vector Laboratories) and streptavidin AlexaFluor 488 conjugate (1:1,000, Molecular Probes). Images were collected on a Nikon A1R confocal microscope and analyzed using ImageJ.
Patch clamp recording
To confirm chemogenetic modulation of CRH neurons, whole-cell patch clamp recordings were performed on visually identified CRH neurons expressing Gi DREADD or AAV-GFP in hippocampal coronal slices (350 μm). An internal solution containing (in mM): 130 K-gluconate, 10 KCl, 4 NaCl, 10 HEPES, 0.1 EGTA, 2 Mg-ATP, 0.3 Na-GTP (pH = 7.25, 280–290 mOsm) and electrodes with DC resistance of 5–8 MΩ were used to record changes in the firing rate and resting membrane potential (RMP) following bath application of CNO (500nM). The RMP was measured over a 100 ms, action potential-free period immediately before application of CNO and compared to the RMP after stabilization following CNO administration. Series resistance and whole-cell capacitance were monitored throughout the recording period and slices were excluded from the dataset if these values changed by >20% during the experiment.
Field potential recording
Transverse hippocampal sections (400 μm) were collected from adult male ChR/CRH mice and Cre-/- littermates. First, mice were anesthetized by isoflurane inhalation, decapitated, and their brains rapidly removed into ice-cold sucrose cutting solution containing (in mM): 3 KCl, 87 NaCl, 7 MgCl2-6H2O, 1.25 NaH2PO4, 0.5 CaCl2-2H2O, 50 sucrose, 25 dextrose, and 25 NaHCO3. Sections were then cut using a Leica vibratome and incubated at 36°C in normal artificial cerebrospinal fluid (nACSF) containing (in mM) 126 NaCl, 2.5 KCl, 2 MgCl2-6H2O, 1.25 NaH2PO4, 2 CaCl2-2H2O, 10 dextrose, 1.5 sodium pyruvate, 1 L-glutamine, and 26 NaHCO3. Sections were incubated for at least one hour before being transferred to the recording chamber, which was maintained at 34°C by an in-line heater (Warner Instruments) and perfused continuously at a rate of 6 mL/minute with nACSF throughout the experiment. All solutions were continuously bubbled with 95% O2 and 5% CO2.
Evoked field potentials from the mossy fiber/associative commissural fiber-CA3 pathway were recorded using a DP-311 differential amplifier (Warner Instruments) and LabChart 7 data acquisition software (AD Instruments). A bipolar tungsten electrode was used to deliver stimuli and a micropipette made of borosilicate glass (World Precision Instruments) with DC resistance of 5–8 MΩ, backfilled with nACSF and its tip gently broken off to reduce series resistance and improve sensitivity, was used for extracellular field recordings. Postsynaptic field excitatory postsynaptic potentials (fEPSPs) were evoked by stimulating over stratum radiatum of CA3 at the border of the hilus and the responses were recorded in stratum radiatum of CA3 at least 500 μm from the stimulating electrode. After a threshold stimulation intensity was determined by recording a threshold response at a width (W) of 60 μs with no response at 20 μs, input-output curves were generated by increasing the stimulus pulse width from 20 to 240 μsec in 20 μsec steps, applying four stimuli per pulse width at 0.1 Hz. The maximum slope of the responses (volts per second) was measured over a 0.5–1 ms window of the fEPSP rising phase and the average slope was calculated at each W used for each recording. Input/output curves were fit with a Boltzmann equation: f(W) = (MAX/(1 + exp((W—W50)/k)) + MAX), where W is stimulus width, MAX is the maximum response, k is a slope factor, and W50 is the stimulus width that elicits 50% of MAX.
Behavior testing
Behavioral experiments were run at the same time of day (between 10am and 4pm) in at least three separate cohorts of animals with all experimental groups represented to ensure reproducibility and to control for batch effects. Males and females were used for all experiments. We did not observe a sex difference in any of the behaviors assessed and therefore the data have been collapsed across sex. All behavior experiments were conducted in the Tufts Center for Neuroscience Research, P30 NS047243 (Jackson). Mice were acclimated to the testing facility for one hour before testing. Additionally, DREADD-injected mice and sham- or GFP-injected littermate controls were acclimated to i.p. injection once daily for three days before testing. Clozapine N-oxide (CNO, 10 mg/kg) was administered i.p. to these animals 40 minutes before testing (before acquisition training only, in the fear conditioning and object recognition experiments) to permit peak DREADD activation [17]. AAV-GFP controls were also treated with CNO to assess any off-target effects [18]. All enclosures were cleaned using 70% ethanol between tests to remove odor cues.
Open field test
Locomotor activity and anxiety-like behavior were assessed using the open field test [19]. Each mouse was placed in the center of a 40cm x 40cm open field enclosure with 16 x 16 equally spaced photocells (Hamilton-Kinder). The total number of beam breaks and the distance traveled and time spent in the center of the enclosure were measured for 10 min using MotorMonitor software (Hamilton-Kinder).
Light/dark box test
The light/dark box test was also used to assess anxiety-like behavior, as it is generally considered more sensitive than the open field test in this regard [19]. Each mouse was placed in the open, illuminated compartment of a 22cm x 43cm light/dark box enclosure with 4 x 8 equally spaced photocells (Hamilton-Kinder). The total number of beam breaks and the distance traveled and time spent in the light compartment of the enclosure were measured for 10 min using MotorMonitor software.
Forced swim test
The forced swim test was employed to evaluate depression-like behavior [20]. Each mouse was placed into a cylinder (21cm diameter) containing approximately 2 L of water at room temperature (22–25°C). Each trial was videotaped, and the latency to immobility and total time spent immobile over 6 min were measured by an investigator blind to the experimental group.
Fear conditioning
Hippocampal-dependent and hippocampal-independent learning and memory were assessed by employing contextual and cued fear memory, respectively, in the tone-shock classical fear conditioning paradigm [21–23]. Experiments were conducted at the same time of day training and contextual memory were performed between 10am-12pm and cued retrieval was performed at 3-5pm. For fear memory acquisition, each mouse was placed in a rectangular box with a steel grid floor (Coulbourn Instruments, 12”W x 10”D x 12”H) and allowed to acclimate for 3 min. The mouse was then given two 20 sec tones (2800 Hz, 80 dB) 1 min apart, each of which ended with a 2 sec, 0.7 mA foot shock. Fear memory retrieval was tested the following day. Each mouse was returned to the same rectangular box, and freezing behavior was measured for 3 min in the absence of tone or shock to assess contextual fear memory retrieval. Mice were then returned to their home cage for at least 3 hours before cued fear memory retrieval. In the cued retrieval test, each mouse was placed in a rectangular plastic container with black and white vertical stripes along the sides and bedding scented with 1% acetic acid. In this novel context, each mouse was presented with the same tones delivered during acquisition but no foot shocks. Freezing behavior was measured for a 3 min baseline period, and throughout the 20 sec tones and subsequent 1 min gaps. Freezing behavior was analyzed using Actimetrics FreezeFrame software (Coulbourn Instruments; bout length 1 sec), and percent time freezing was calculated for contextual and cued retrieval [22].
Object recognition memory
The object recognition memory test was applied to assess recognition memory. Mice were acclimated to empty bedding-free test chambers (6”W x 10”D x 5.5”H) for 10 min daily for three days before testing. On the first testing day, each mouse was moved into a bedding-free acquisition chamber with two identical objects (stainless steel hex bolts) fixed to the floor at opposite ends of the chamber. The chamber was videotaped for 5 min while mice explored the chamber and became familiar with the objects. Each mouse underwent this familiarization trial three times, with a 15 min interval between trials. After a 3-hour retention interval, each mouse was moved into a bedding-free retrieval chamber with one familiar object (stainless steel hex bolt) and one novel object (cylindrical nylon washer) of similar sizes and fixed on opposite ends of the chamber, and a 5 min exploration session was videotaped. Finally, after a 24-hour retention interval, the retrieval session was repeated using an alternate novel object (rectangular plastic block). All sessions were then evaluated for object preference ratios by an investigator blind to the experimental group. The location of the novel object (left versus right end of the chamber), was counterbalanced across experimental groups to control for nonspecific location preference effects, and the left:right ratio from familiarization trials was calculated to quantify any such preference.
Stress paradigms
Restraint stress was applied by coaxing mice headfirst into 50 mL falcon tubes with air holes cut in the conical tips to allow breathing, and capping the tubes to prevent escape. Acute stress consisted of a single 30 min session, while chronic stress consisted of 14 consecutive daily 30 min sessions. Foot shock stress consisted of the acquisition phase of the tone-shock classical fear conditioning paradigm described above. In all stress paradigms, mice were sacrificed 1 hr after the beginning of the final stressor to capture immediate early gene expression in stress-associated brain regions.
EEG recording
One week after the end of behavioral testing, EEG recording was performed to quantitatively assess the severity of kainic acid (KA) -induced seizures [24]. EEG recordings were performed using a preamplifier with 100x gain and a 1.0 Hz high-pass filter (Pinnacle Technology, part #8202-SE). LabChart Pro software (ADInstruments) was used for data acquisition and analysis. A 10 min baseline period was recorded prior to an i.p. injection with 10 mg/kg KA dissolved in 0.9% NaCl injection saline and EEG activity was then recorded for an additional 2 hr period. Electrographic seizure activity was identified as an event at least 2.5 times the standard deviation of the baseline signal in amplitude and at least 5 sec in duration, as previously described [25]. Additionally, periods of rhythmic spiking lasting at least 30 sec and clearly distinct from baseline activity in frequency and amplitude were identified by visual inspection; these abnormal electrographic events were considered along with seizure activity collectively as “epileptiform activity” [25–27]. For each animal, the total duration of epileptiform activity was calculated, as well as the average duration of each epileptiform event and the latency from KA injection to the first event. Finally, in order to distinguish between periods of high-frequency (ictal-like) and low-frequency (interictal-like) seizure activity, data was high-pass filtered at 15 Hz and band-pass filtered from 1 to 3 Hz, respectively [27].
Statistical analysis
All data are reported as mean ± SEM. For object recognition memory data, a one sample t-test was used to evaluate each experimental group’s novel:familiar exploration ratio against a hypothetical mean of 1.00 (i.e. chance). All other behavioral datasets employed a two-way ANOVA to identify main effects of sex, main effects of injected virus, and interactions between the two, followed by Tukey’s honest significant difference (HSD) test for pairwise group comparisons. For c-fos colocalization experiments, one-way ANOVA was employed, followed by Tukey’s HSD test. A Student’s t-test was used for all other experiments to determine significant differences between experimental groups.
Results
The BAC CRH-Cre mouse is a useful tool for manipulating a subset of hippocampal CRH neurons
Multiple mouse lines intended to target Cre recombinase expression specifically to CRH neurons are now available, and variations in the expression patterns among these lines have recently been described [28, 29]. The BAC CRH-Cre mice were generated using a modified bacterial artificial chromosome (BAC) containing Cre under control of the CRH-specific promoter. It is accepted that BAC transgenics often accurrately recapitulate the spatial and temporal pattern of gene expression [30]. The CRH-ires-Cre mice are knock-in mice generated in which Cre recombinase expression is driven by endogenous promoter/enhancer elements [31]. The fidelity of Cre recombinase expression in the BAC CRH-Cre line has recently been questioned [28], although the reported expression pattern does not match our findings [16, 32]. In order to determine whether the BAC CRH-Cre line faithfully targets Cre expression to bona fide hippocampal CRH neurons, we assessed CRH reporter (tdTomato) expression and its colocalization with CRH peptide immunoreactivity in BAC CRH-Cre/Ai9 and CRH-ires-Cre/Ai9 hippocampal sections. CRH-ires-Cre/Ai9 sections displayed substantial reporter expression through multiple strata of CA1 and the dentate gyrus, with more limited expression in CA3 (Fig 1b and 1c). In contrast, BAC CRH-Cre/Ai9 reporter was restricted primarily to stratum pyramidale of area CA1, with some additional expression in CA3 stratum pyramidale and sparse expression in any other subregion (Fig 1a and 1c). In each line, the pattern of reporter expression was consistent between dorsal and ventral aspects of the hippocampus (data not shown). Additionally, BAC CRH-Cre/Ai9 sections displayed considerable colocalization between the reporter and CRH immunoreactivity in stratum pyramidale of CA1 (63.4%) and CA3 (55.8%), while CRH-ires-Cre/Ai9 sections showed lower colocalization in these hippocampal subregions (32.4% and 30.4% respectively) (n = 4 matched sections per mouse, 4 mice per experimental group). These results suggest that multiple distinct subpopulations of hippocampal CRH neurons exist, and further indicate that the BAC CRH-Cre line faithfully captures one subpopulation which resides principally in CA1 stratum pyramidale, as we previously described [12]. The restricted expression of Cre in the BAC CRH-Cre line enables us to focus specifically on the function of this unique population of hippocampal interneurons for all further experiments.
Hippocampal CRH neurons exhibit low basal activation and are recruited under hyperexcitable conditions
In an attempt to determine under what conditions hippocampal CRH neurons are engaged, as a first pass, we employed immunostaining of the immediate early gene c-fos, which is sharply upregulated and translocated to the nucleus following periods of heightened synaptic activity [33]. Starting from the basic assumption that a neuronal population’s relative synaptic activity increases during states or tasks to which it is functionally relevant, we tested the longstanding hypothesis that hippocampal CRH neurons are important for mediating the effects of stress on the hippocampus [34–36]. First as a positive control, kainic acid-induced seizures gave rise to extensive c-fos induction among CRH neurons (57.2 ± 15.1%) compared to saline-injected littermate controls (2.3 ± 1.0%), demonstrating that this approach can discriminate periods of high activity (Fig 2b). Unexpectedly, c-fos expression in this subset of hippocampal CRH neurons did not change after subjection to acute restraint stress (2.6 ± 2.6%) nor after chronic restraint stress (7.0 ± 4.4%), compared to minimally-handled littermate controls (6.9 ± 2.3%) (Fig 2b), in contrast to CRH neurons in the paraventricular nucleus (PVN), which are highly activated by stress [37]. An alternative stressor, foot-shock stress, gave rise to a marginal, non-significant trend toward increased c-fos induction (12.2 ± 1.5%) (Fig 2b) (n = 3–4 mice per experimental group). Collectively these data indicate that hippocampal CRH neurons exhibit low basal activity and are heavily recruited in hyperexcited network states but not in stress states.
Validating cell type-specific manipulations of hippocampal CRH neurons
In order to further probe the functional relevance of this subset of hippocampal CRH neurons, we next employed chemogenetic tools to selectively manipulate these neurons in vivo. We began by validating these tools histologically. To selectively activate this population, BAC CRH-Cre mice were infused with a virus expressing excitatory (Gq) Designer Receptors Exclusively Activated by Designer Drugs (DREADD). Hippocampal CRH neurons from these mice displayed a significant increase in c-fos expression (56.1%) 1 hr after i.p. CNO injection (Fig 3a and 3c). Conversely, BAC CRH-Cre mice infused with inhibitory (Gi) DREADD-expressing virus showed minimal c-fos expression among hippocampal CRH neurons (4.3%) following CNO administration (Fig 3b and 3c) (n = 3 mice per experimental group). Finally, to irreversibly remove mature hippocampal CRH neurons from the network, we employed a virus that expresses fragment A of diphtheria toxin (DTA) in a Cre recombinase-dependent fashion, along with a Cre recombinase-independent red fluorescent reporter to mark adjacent surviving (i.e. Cre-negative) cells. To assess the loss of CRH neurons in the AAV-Flex-DTA animals, we compared the number of CRH-positive neurons throughout the CA1 region of the hippocampus in mice stereotaxically injected with AAV-Flex-DTA compared to AAV-GFP. Three weeks following viral injections, there is a 30.2 ± 3.3% reduction in the number of CRH-positive neurons in the CA1 region of the hippocampus (data not shown; n = 4–5 mice per experimental group). These data indicate that we can effectively express Gi and Gq DREADDs and AAV-Flex-DTA specifically in CRH neurons in the hippocampus.
The inhibition of hippocampal CRH neurons using Gi DREADDs was functionally confirmed using electrophysiological methods. The resting membrane potential of hippocampal CRH neurons expressing Gi DREADDs was decreased in the presence of CNO (-9.1 ± 4.0 mV). However, the addition of CNO did not significantly alter the resting membrane potential in hippocampal CRH neurons expressing only GFP (1.3 ± 0.5 mV) (S1 Fig; n = 7–8 cells, 4 mice per experimental group; p<0.05 using a paired Student’s t-test).
Hippocampal CRH neuron activation suppresses excitability of the mossy fiber-CA3 pathway
We previously demonstrated that hippocampal CRH neurons back-project to form extensive inhibitory synapses on CA3 pyramidal neurons [12]. Therefore, we hypothesized that manipulating hippocampal CRH neurons’ synaptic output would impact the excitability of CA3. In order to test this hypothesis at the local network level, we employed field potential recording at the mossy fiber-CA3 synapse in conjunction with optogenetics (Fig 4a). Since this subset of hippocampal CRH neurons backprojects from CA1 to CA3, we tested the ability of optogenetic stimulation of the terminals onto CA3 pyramidal neurons to alter the population response to stimulation of the inputs onto these neurons coming from the dentate gyrus. Mossy fibers were electrically stimulated and fEPSPs were recorded in area CA3 to generate an input-output curve. After a 10 min recovery interval, a second input-output curve was generated while the hippocampal CRH terminals in area CA3 were illuminated by a 473nm laser (5msec pulses at 20 Hz) (Fig 4b and 4c). In slices from Cre-/- mice, laser illumination had no impact on the half-maximal width of the input-output curve (baseline: 124.0 ± 10.6 μsec; laser on: 123.6 ± 13.5 μsec) or the peak fEPSP amplitude (97.0 ± 15.6% of baseline) (Fig 4d and 4e). In slices from ChR/CRH mice, laser illumination had no effect on half-maximal width (baseline: 128.4 ± 10.3 μsec; laser on: 126.2 ± 16.3 μsec) but strongly attenuated peak fEPSP amplitude (56.1 ± 6.0% of baseline) (Fig 4d and 4e) (n = 5–7 mice per experimental group; p<0.01 by paired Student’s t-test). These data demonstrate that hippocampal CRH neuron activation alone is sufficient to potently suppress the excitability of the mossy fiber-CA3 pathway.
Hippocampal CRH neurons regulate locomotor activity and recognition memory
In light of their impact on the excitability of area CA3, we hypothesized that hippocampal CRH neurons play an integral role in hippocampus-dependent behaviors such as emotional behavior and learning and memory. To test this hypothesis we employed a battery of behavioral paradigms while selectively activating, silencing, or ablating hippocampal CRH neurons with excitatory DREADD (Gq), inhibitory DREADD (Gi), and DTA, respectively.
Selective activation of hippocampal CRH neurons by Gq did not alter locomotor activity (3379 ± 220 basic movements) or anxiety-like behavior in the open field (10.9 ± 3.0% time in center) compared to vehicle-injected controls (3095 ± 25 basic movements; 9.3 ± 3.1% time in center). Similarly, activation did not alter locomotor activity (1791 ± 139 basic movements) or anxiety-like behavior in the light-dark box (5.0 ± 3.3% time in light) compared to controls (1614 ± 126 basic movements; 2.6 ± 0.3% time in light) (Fig 5) (n = 12–17 mice per experimental group). Finally, selective activation had no impact on behavior in the forced swim test (latency to immobility: Gq: 53.0 ± 15.3 s; Control: 65.0 ± 34.5 s; total time immobile: Gq: 253.0 ± 8.1 s; Control: 234.0 ± 33.5 s) (S2 Fig).
Given our uncertainty over the relationship between the real time activity of hippocampal CRH neuron and physiological states (Fig 2), we next reasoned that silencing or ablating these neurons—effectively removing them from the hippocampal network—would be a more effective approach than activation for revealing their functional significance. Silencing CRH neurons using Gi did not significantly alter anxiety-like behavior in the open field (17.4 ± 2.0% time in center) or light-dark box (31.6 ± 2.8% time in light) compared to GFP-injected controls (13.2 ± 2.2% time in center; 22.0 ± 6.3% time in light) (Fig 5b). Surprisingly, silencing did produce a locomotor hyperactivity phenotype in both the open field (Gi: 3696 ± 242 basic movements; Control: 2605 ± 169 basic movements; p<0.005 by Tukey’s HSD test) and light-dark box (Gi: 2435 ± 115 basic movements; Control: 1788 ± 74 basic movements; p<0.001 by Tukey’s HSD test) (Fig 5a). Similarly, ablating CRH neurons with DTA did not impact anxiety-like behavior (DTA: 18.9 ± 1.7% time in center; Control: 18.9 ± 1.8% time in center), nor was locomotor activity in the open field test altered (DTA: 3441 ± 224 basic movements; Control: 3088 ± 161 basic movements) (Fig 5). Ablation of hippocampal CRH neurons did not significantly impact behavior in the light-dark box (22.9 ± 3.8% time in light; 2205 ± 167 basic movements) compared to controls (20.2 ± 2.7% time in light; 1987 ± 104 basic movements) (Fig 5). Depression-like behavior was also not significantly altered by silencing (Gi: 194 ± 10 sec immobile; Control: 198 ± 9 sec immobile) or ablating CRH neurons (DTA: 209 ± 20 sec immobile; Control: 218 ± 16 sec immobile) (data not shown).
Cued fear memory acquisition, which is thought to be largely hippocampus-independent, was not significantly altered by silencing (Gi: 28.1 ± 5.5% freezing; Control: 39.8 ± 5.3% freezing) or ablating hippocampal CRH neurons (DTA: 40.1 ± 6.4% freezing; Control: 34.7 ± 5.2% freezing) (Fig 6). Interestingly, hippocampus-dependent contextual fear memory acquisition was also intact after both silencing (Gi: 25.8 ± 4.4% freezing; Control: 35.5 ± 7.4% freezing) and ablation of hippocampal CRH neurons (DTA: 24.2 ± 3.6% freezing; Control: 29.9 ± 4.7% freezing) (Fig 6) (n = 14–16 mice per experimental group).
Because silencing CRH neurons increased locomotor activity, it is possible that any changes in hippocampus-dependent fear memory acquisition were masked by hyperactivity. Therefore we decided to test recognition memory using a paradigm that internally controls for locomotor activity, the object recognition memory test [38]. In a retention trial 24 hours after familiarization training, neither silencing nor ablation of CRH neurons impaired mice’s ability to discriminate between a novel object and a familiar one (Gi: 2.30 ± 0.36 novel:familiar ratio, p<0.05 from a hypothetical mean of 1.00 by one sample t-test; DTA: 2.58 ± 0.52 novel:familiar ratio, p<0.05 from a hypothetical mean of 1.00 by one sample t-test). However, after a 3 hour retention interval, mice whose CRH neurons were selectively ablated by DTA failed to discriminate between the novel and familiar objects (1.15 ± 0.12 novel:familiar ratio) (n = 12–16 mice per experimental group; p = 0.235 from a hypothetical mean of 1.00 by one sample t-test), in contrast to GFP-injected control littermates which preferentially explored the novel object (1.50 ± 0.20 novel:familiar ratio, p<0.05 from a hypothetical mean of 1.00 by one sample t-test) (Fig 7).
Together our behavior data indicate that CRH neurons of the dorsal hippocampus are important for modulating both locomotor activity and recognition memory.
Hippocampal CRH neurons modulate the severity of kainic acid-induced seizures
Ample evidence implicates abnormal hippocampal GABAergic signaling in the pathophysiology of temporal lobe epilepsy [39–41]. Additionally, our field recording experiments indicate that hippocampal CRH neurons exert a robust influence over the excitability of area CA3. Thus we hypothesized that manipulating hippocampal CRH neurons would be sufficient to modulate seizure susceptibility in the systemic KA model of temporal lobe epilepsy. Selective ablation of hippocampal CRH neurons by DTA gave rise to a profound increase in the proportion of time spent seizing (50.0 ± 6.4%) compared to GFP-injected controls (10.5 ± 1.3%; p<0.01 by unpaired Student’s t-test) (Fig 8a and 8b) (n = 6 mice per experimental group). Unexpectedly, selective silencing by Gi had no impact on seizure severity (Gi+CNO: 35.5 ± 8.2%; GFP+CNO: 32.0 ± 6.1%; n.s. by unpaired Student’s t-test) (Fig 8c and 8d) (n = 7–9 mice per experimental group). The additional stress of CNO injection or off-target effects of CNO [18] in the latter experiment might have exacerbated seizure susceptibility (cf. Fig 8b AAV-GFP vs Fig 8d GFP+CNO), masking any proconvulsant effect of CRH neuron silencing. A more detailed analysis of electrographic seizure activity further revealed that mice receiving DTA spent significantly more time displaying high-frequency ictal discharges (34.2 ± 9.7%) than GFP-injected controls (8.9 ± 1.4%; p<0.05 by unpaired Student’s t-test) (data not shown).
Model of hippocampal CRH neuron function
Based on our experimental manipulations of CRH interneurons, we propose a model to describe CRH interneurons’ functional role within the hippocampal network. Basally (i.e. when input to the hippocampal network is within a “normal” range, CRH interneurons exhibit low levels of synaptic output (Fig 9a). During periods of relatively high activation of the hippocampal network (e.g. temporal lobe seizures, exploration of a novel context), hippocampal CRH neurons are recruited to increase their GABAergic output onto CA3 principal neurons (Fig 9b), thereby suppressing activation of CA3 by mossy fibers and restraining the final output from CA1 principal cells within an adaptive range. In the absence of CRH neuron activity (either through chemogenetic silencing or ablation, high hippocampal network activity goes unchecked, resulting in a high level of CA1 output (Fig 9c) which is (1) permissive of temporal lobe seizures and (2) outside the optimal range for learning and memory.
Discussion
Selective silencing or ablation of hippocampal CRH neurons produced a deficit in recognition memory, locomotor hyperactivity, and hypersensitivity to kainic-acid induced seizures. Additionally, stimulation of hippocampal CRH neurons reduced the excitability of the mossy fiber-CA3 pathway. Taken together, these results suggest that hippocampal CRH neurons are critical for maintaining an adaptive range of excitability that permits normal recognition memory and experience-dependent plasticity, and especially for counterbalancing activation of the hippocampal network in hyperexcited states like seizures. Importantly, considering the abundance of hippocampal interneuron types and the relative sparsity of hippocampal CRH neurons, our results further indicate that the unique back-projecting connectivity of CRH neurons imbues them with a disproportionately strong influence on the excitability of the hippocampal network. This model of hippocampal CRH neuron function is meant as a starting point to invite specific testing and refinement through future experiments. However, it is important to note that we did not assess non-selective silencing or ablation of non-CRH neurons in the hippocampus which may also alter hippocampal network excitability and impact these behaviors and/or epileptiform activity as well.
Hippocampal CRH neuron activity across physiological states
Although we demonstrated that hippocampal CRH neurons are recruited in the pathological state of acute seizures, we have yet to identify a physiological state in which this population is highly active. The main drawback of using c-fos immunoreactivity as an activity marker is its temporal resolution, as this approach offers only a static snapshot of all recently active neurons. Selective ablation or silencing of CRH neurons indicated that their activity as a population is importantly involved in the overall function of the trisynaptic circuit; on the other hand, only in the extreme circumstance of a KA-induced seizure did they show a population-level increase in c-fos expression.
Dorsal and ventral hippocampus
Another major question we have yet to address is that of potentially separable functional roles for CRH neurons in the dorsal and ventral divisions of the hippocampus. In this study we focused on manipulating CRH neurons in the dorsal hippocampus in vivo, but through histology we observed similar anatomical distributions of CRH reporter-expressing cells and similar patterns of activity marker expression in both divisions. A substantial body of work indicates that the dorsal/posterior division of the hippocampus is involved in largely emotionally-neutral episodic memory processing and spatial navigation, while the ventral/anterior division is specialized for emotional information processing including some aspects of stress reactivity (for review see [42, 43]). Thus it is plausible that we observed effects on memory but not on stress-reactive emotional behavior precisely because our selective manipulation of CRH neurons focused solely on the dorsal subpopulation. It will be important in the future to test whether a functionally distinct subpopulation of CRH interneurons exists in each anatomical division of the hippocampus.
GABAergic versus peptidergic signaling
The network excitability effects we observe after silencing and stimulating hippocampal CRH neurons are consistent with respectively lower and higher levels of GABA release onto CA3 principal cells. On the other hand, we cannot yet account for corresponding changes in hippocampal CRH receptor signaling, and a full treatment of hippocampal CRH neurons’ function must reconcile their otherwise contradictory inhibitory (synaptic) and excitatory (peptidergic) modes of transmission. An important obstacle to achieving this reconciliation is the dearth of prior research into the basic mechanism of peptide release, in contrast to the thoroughly-studied mechanism of synaptic vesicle exocytosis [44, 45]. It is generally understood that brief, local elevations of intracellular calcium are sufficient to trigger neurotransmitter release, whereas exocytosis of dense core vesicles containing neuropeptides and other high molecular weight signaling molecules requires more sustained, diffuse calcium influx [46]. Beyond this, little is yet known about the molecular mechanisms underlying dense core vesicle exocytosis, so for now the field relies on pharmacology of CRH receptors and direct application of exogenous CRH to infer its function [13, 34]. These approaches are beset with limitations: first, the CRH receptor has multiple endogenous cognate ligands with multiple regional sources [47]; second, the effective range of volume transmission for these ligands remains unknown, so distant brain regions cannot be ruled out as sources of hippocampal CRH; and third, the physiologically relevant concentrations of hippocampal CRH in various brain states have yet to be accurately measured. However, powerful novel approaches, such as Chinese hamster ovary “sniffer” cells in conjunction with slice electrophysiology, promise to shed light on peptidergic signaling in the future [48, 49].
In summary, future investigations into back-projection CRH interneurons should focus on disentangling their GABA-dependent versus CRH-dependent functions, identifying different functional roles for their dorsal versus ventral hippocampal sub-populations, and assessing how their activity changes as a function of physiological state. The same lines of inquiry are also worth following for other hippocampal interneuron classes, specifically those that express additional signaling molecules like somatostatin and are present in both the dorsal and ventral aspects of the hippocampus.
Supporting information
Acknowledgments
The authors thank Dr. Patrick Fuller for his generous gift of AAV-FLEX-DTA. All imaging and behavior data were acquired through the Tufts Center for Neuroscience Research, P30 NS047243 (Jackson).
Data Availability
All relevant data are presented within the manuscript text and figures.
Funding Statement
J.M. was supported by NS073574 (J.M.) and NS102937 (J.M.). Development of AAV-DTA was supported by NS092652 (P.M.F.). A.H. was supported by a predoctoral fellowship from the Epilepsy Foundation and the Dean’s Award from Tufts University School of Medicine. SAGE Therapeutics provided support in the form of salaries for authors (JM), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Eichenbaum H. What H.M. taught us. J Cogn Neurosci 2013;25:14–21. doi: 10.1162/jocn_a_00285 [DOI] [PubMed] [Google Scholar]
- 2.Howard MW, Eichenbaum H. Time and space in the hippocampus. Brain Res 2015;1621:345–54. doi: 10.1016/j.brainres.2014.10.069 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Klausberger T, Somogyi P. Neuronal Diversity and Temporal Dynamics: The Unity of Hippocampal Circuit Operations. Science 2008;321:53–7. doi: 10.1126/science.1149381 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Buzsaki G. Hippocampal sharp wave-ripple: A cognitive biomarker for episodic memory and planning. Hippocampus 2015;25:1073–188. doi: 10.1002/hipo.22488 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Hunt RF, Girskis KM, Rubenstein JL, Alvarez-Buylla A, Baraban SC. GABA progenitors grafted into the adult epileptic brain control seizures and abnormal behavior. Nat Neurosci 2013;16:692–7. doi: 10.1038/nn.3392 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Marx M, Haas CA, Haussler U. Differential vulnerability of interneurons in the epileptic hippocampus. Front Cell Neurosci 2013;7:167 doi: 10.3389/fncel.2013.00167 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Csicsvari J, Hirase H, Czurko A, Mamiya A, Buzsaki G. Oscillatory coupling of hippocampal pyramidal cells and interneurons in the behaving Rat. J Neurosci 1999;19:274–87. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Stark E, Roux L, Eichler R, Senzai Y, Royer S, Buzsaki G. Pyramidal cell-interneuron interactions underlie hippocampal ripple oscillations. Neuron 2014;83:467–80. doi: 10.1016/j.neuron.2014.06.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Klausberger T, Magill PJ, Marton LF, Roberts JD, Cobden PM, Buzsaki G et al. Brain-state- and cell-type-specific firing of hippocampal interneurons in vivo. Nature 2003;421:844–8. doi: 10.1038/nature01374 [DOI] [PubMed] [Google Scholar]
- 10.Maurer AP, Cowen SL, Burke SN, Barnes CA, McNaughton BL. Phase precession in hippocampal interneurons showing strong functional coupling to individual pyramidal cells. J Neurosci 2006;26:13485–92. doi: 10.1523/JNEUROSCI.2882-06.2006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Jiruska P, Alvarado-Rojas C, Schevon CA, Staba R, Stacey W, Wendling F et al. Update on the mechanisms and roles of high-frequency oscillations in seizures and epileptic disorders. Epilepsia 2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Hooper A, Maguire J. Characterization of a novel subtype of hippocampal interneurons that express corticotropin-releasing hormone. Hippocampus 2016;26:41–53. doi: 10.1002/hipo.22487 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Blank T, Nijholt I, Eckart K, Spiess J. Priming of long-term potentiation in mouse hippocampus by corticotropin-releasing factor and acute stress: implications for hippocampus-dependent learning. J Neurosci 2002;22:3788–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Chen Y, Kramar EA, Chen LY, Babayan AH, Andres AL, Gall CM et al. Impairment of synaptic plasticity by the stress mediator CRH involves selective destruction of thin dendritic spines via RhoA signaling. Mol Psychiatry 2013;18:485–96. doi: 10.1038/mp.2012.17 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.National Research Council. Guide for the care and use of laboratory animals. National Academies Press; 2011. [PubMed] [Google Scholar]
- 16.Sarkar J, Wakefield S, Mackenzie G, Moss SJ, Maguire J. Neurosteroidogenesis Is Required for the Physiological Response to Stress: Role of Neurosteroid-Sensitive GABAA Receptors. J Neurosci 2011;31:18198–210. doi: 10.1523/JNEUROSCI.2560-11.2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Alexander GM, Rogan SC, Abbas AI, Armbruster BN, Pei Y, Allen JA et al. Remote control of neuronal activity in transgenic mice expressing evolved G protein-coupled receptors. Neuron 2009;63:27–39. doi: 10.1016/j.neuron.2009.06.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Gomez JL, Bonaventura J, Lesniak W, Mathews WB, Sysa-Shah P, Rodriguez LA et al. Chemogenetics revealed: DREADD occupancy and activation via converted clozapine. Science 2017;357:503 doi: 10.1126/science.aan2475 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Holter SM, Einicke J, Sperling B, Zimprich A, Garrett L, Fuchs H et al. Tests for Anxiety-Related Behavior in Mice. Curr Protoc Mouse Biol 2015;5:291–309. doi: 10.1002/9780470942390.mo150010 [DOI] [PubMed] [Google Scholar]
- 20.Yan HC, Cao X, Das M, Zhu XH, Gao TM. Behavioral animal models of depression. Neurosci Bull 2010;26:327–37. doi: 10.1007/s12264-010-0323-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.LeDoux JE. Brain mechanisms of emotion and emotional learning. Curr Opin Neurobiol 1992;2:191–7. [DOI] [PubMed] [Google Scholar]
- 22.Kittelberger KA, Piazza F, Tesco G, Reijmers LG. Natural amyloid-beta oligomers acutely impair the formation of a contextual fear memory in mice. PLoS One 2012;7:e29940 doi: 10.1371/journal.pone.0029940 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Bergstrom HC. The neurocircuitry of remote cued fear memory. Neurosci Biobehav Rev 2016;71:409–17. doi: 10.1016/j.neubiorev.2016.09.028 [DOI] [PubMed] [Google Scholar]
- 24.Levesque M, Avoli M. The kainic acid model of temporal lobe epilepsy. Neurosci Biobehav Rev 2013;37:2887–99. doi: 10.1016/j.neubiorev.2013.10.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.O′Toole KK, Hooper A, Wakefield S, Maguire J. Seizure-induced disinhibition of the HPA axis increases seizure susceptibility. Epilepsy Res 2014;108:29–43. doi: 10.1016/j.eplepsyres.2013.10.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Castro OW, Santos VR, Pun RYK, McKlveen JM, Batie M, Holland KD et al. Impact of Corticosterone Treatment on Spontaneous Seizure Frequency and Epileptiform Activity in Mice with Chronic Epilepsy. PLoS ONE 2012;7:e46044 doi: 10.1371/journal.pone.0046044 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Sivakumaran S, Maguire J. Bumetanide reduces seizure progression and the development of pharmacoresistant status epilepticus. Epilepsia 2016;57:222–32. doi: 10.1111/epi.13270 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Chen Y, Molet J, Gunn BG, Ressler K, Baram TZ. Diversity of Reporter Expression Patterns in Transgenic Mouse Lines Targeting Corticotropin-Releasing Hormone-Expressing Neurons. Endocrinology 2015;156:4769–80. doi: 10.1210/en.2015-1673 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Kono J, Konno K, Talukder AH, Fuse T, Abe M, Uchida K et al. Distribution of corticotropin-releasing factor neurons in the mouse brain: a study using corticotropin-releasing factor-modified yellow fluorescent protein knock-in mouse. Brain Struct Funct 2016. [DOI] [PubMed] [Google Scholar]
- 30.Heintz N. Bac to the future: The use of bac transgenic mice for neuroscience research. Nature Reviews Neuroscience 2001;2:861 doi: 10.1038/35104049 [DOI] [PubMed] [Google Scholar]
- 31.Taniguchi H, He M, Wu P, Kim S, Paik R, Sugino K et al. A Resource of Cre Driver Lines for Genetic Targeting of GABAergic Neurons in Cerebral Cortex. Neuron 2011;71:995–1013. doi: 10.1016/j.neuron.2011.07.026 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Melón L, Hooper A, Yang X, Moss SJ, Maguire J. Inability to suppress the stress-induced activation of the HPA axis engenders deficits in postpartum behaviors in mice. Psychoneuroendocrinology 2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Caputto BL, Guido ME. Immediate early gene expression within the visual system: light and circadian regulation in the retina and the suprachiasmatic nucleus. Neurochem Res 2000;25:153–62. [DOI] [PubMed] [Google Scholar]
- 34.Chen Y, Dube CM, Rice CJ, Baram TZ. Rapid loss of dendritic spines after stress involves derangement of spine dynamics by corticotropin-releasing hormone. J Neurosci 2008;28:2903–11. doi: 10.1523/JNEUROSCI.0225-08.2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Chen Y, Rex CS, Rice CJ, Dube CM, Gall CM, Lynch G et al. Correlated memory defects and hippocampal dendritic spine loss after acute stress involve corticotropin-releasing hormone signaling. Proc Natl Acad Sci U S A 2010;107:13123–8. doi: 10.1073/pnas.1003825107 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Chen Y, Andres AL, Frotscher M, Baram TZ. Tuning synaptic transmission in the hippocampus by stress: the CRH system. Front Cell Neurosci 2012;6:13 doi: 10.3389/fncel.2012.00013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Lee V, Sarkar J, Maguire J. Loss of Gabrd in CRH neurons blunts the corticosterone response to stress and diminishes stress-related behaviors. Psychoneuroendocrinology 2014;41:75–88. doi: 10.1016/j.psyneuen.2013.12.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Holter SM, Garrett L, Einicke J, Sperling B, Dirscherl P, Zimprich A et al. Assessing Cognition in Mice. Curr Protoc Mouse Biol 2015;5:331–58. doi: 10.1002/9780470942390.mo150068 [DOI] [PubMed] [Google Scholar]
- 39.Brooks-Kayal AR, Shumate MD, Jin H, Rikhter TY, Coulter DA. Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy. Nature Medicine 1998;4:1166–72. doi: 10.1038/2661 [DOI] [PubMed] [Google Scholar]
- 40.Loup F, Wieser HG, Yonekawa Y, Aguzzi A, Fritschy JM. Selective alterations in GABAA receptor subtypes in human temporal lobe epilepsy. J Neurosci 2000;20:5401–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Gonzalez MI, Brooks-Kayal A. Altered GABA(A) receptor expression during epileptogenesis. Neurosci Lett 2011;497:218–22. doi: 10.1016/j.neulet.2011.02.052 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Fanselow MS, Dong HW. Are the dorsal and ventral hippocampus functionally distinct structures? Neuron 2010;65:7–19. doi: 10.1016/j.neuron.2009.11.031 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Grigoryan G, Segal M. Lasting Differential Effects on Plasticity Induced by Prenatal Stress in Dorsal and Ventral Hippocampus. Neural Plast 2016;2016:2540462 doi: 10.1155/2016/2540462 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Sudhof TC, Rizo J. Synaptic vesicle exocytosis. Cold Spring Harb Perspect Biol 2011;3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Sudhof TC. Neurotransmitter release: the last millisecond in the life of a synaptic vesicle. Neuron 2013;80:675–90. doi: 10.1016/j.neuron.2013.10.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Burgoyne RD, Morgan A. Secretory granule exocytosis. Physiol Rev 2003;83:581–632. doi: 10.1152/physrev.00031.2002 [DOI] [PubMed] [Google Scholar]
- 47.Weninger SC, Dunn AJ, Muglia LJ, Dikkes P, Miczek KA, Swiergiel AH et al. Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH. Proc Natl Acad Sci U S A 1999;96:8283–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Muller-Chretien E. Outside-out "sniffer-patch" clamp technique for in situ measures of neurotransmitter release. Methods Mol Biol 2014;1183:195–204. doi: 10.1007/978-1-4939-1096-0_12 [DOI] [PubMed] [Google Scholar]
- 49.Pinol RA, Jameson H, Popratiloff A, Lee NH, Mendelowitz D. Visualization of oxytocin release that mediates paired pulse facilitation in hypothalamic pathways to brainstem autonomic neurons. PLoS One 2014;9:e112138 doi: 10.1371/journal.pone.0112138 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All relevant data are presented within the manuscript text and figures.